Press release
Rising Gout Incidence Driving Growth In Krystexxa Market: Major Factor in the Transformation of the Krystexxa Market in 2025
Krystexxa Market Size
In recent times, the market size for krystexxa has seen a HCAGR of $XX. The projections show a growth from $XX million in 2024 to $XX million in 2025, with a Compound Annual Growth Rate (CAGR) of $XX%. The historic period growth has been driven by factors such as an increasing geriatric population, a surge in clinical studies, growing prevalence of chronic and refractory conditions, a rising trend of telemedicine in the healthcare system, and an increasing coverage for biological treatments.
The market size of krystexxa is anticipated to experience a future compound annual growth rate of $XX% in the coming years. By 2029, it's predicted to build up to a value of $XX million. This growth can be linked to a surge in chronic diseases prevalence, a rising global population, the increasing need for the use of intravenous pegloticase, a rise in gout incidents, and heightened healthcare spending. Noteworthy trends projected for the forecast period include a movement toward subcutaneous delivery methods, the incorporation of artificial intelligence in clinical trials, technological progression, innovative product introduction, as well as advances in pegylation technology.
What Key Elements Are Boosting Growth in the Krystexxa Market?
The surge in the occurrence of gout disease is anticipated to drive the expansion of the Krystexxa market in the future. Gout disease is a type of arthritis resulting from the accumulation of uric acid crystals in the joints, which leads to discomfort, inflammation, and swelling. The rising number of gout disease cases can be tied to a variety of factors, including unhealthy eating habits, obesity, aging, specific medications, genetic factors, chronic kidney disease, a lack of physical activity, and associated conditions such as hypertension and diabetes. Krystexxa (pegloticase) assists gout patients by reducing the levels of uric acid in their bloodstream, specifically focusing on chronic gout that doesn't respond to traditional treatments. This ultimately diminishes the frequency and intensity of gout outbreaks, offering respite from the painful symptoms linked with the disease. For instance, in June 2024, the Australian Institute of Health and Welfare, a government agency based in Australia, reported that in 2022, gout was implicated in 573 deaths in Australia, amounting to 2.2 fatalities per 100,000 individuals. This made up 0.3% of all deaths and accounted for 5.5% of all fatalities attributed to musculoskeletal conditions. Consequently, the escalating incidence of gout disease is contributing to the growth of the Krystexxa market.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20134&type=smp
Who Are the Major Industry Players Fueling Krystexxa Market Expansion?
Major companies operating in the krystexxa market include Amgen Inc.
Which Key Developments Are Influencing the Krystexxa Market?
A prevailing trend in the krystexxa market is the concentration on combination therapy to optimize effectiveness, curtail the development of anti-drug antibodies, and advance patient results in the control of unchecked gout. Combination therapy implies the combined usage of two or more drugs or treatments to increase effectiveness and better patient outcomes. It is traditionally employed to address various facets of a disease or condition. For instance, in July 2022, Horizon Therapeutics, a biotechnology firm based in Ireland, was granted the supplemental biologics license application (sBLA) by the Food and Drug Administration, a US federal agency, to expand the label to encompass Krystexxa (pegloticase) injection coupled with methotrexate. When utilized together with methotrexate, Krystexxa (pegloticase) injection treats adult patients suffering from uncontrollable chronic gout. This combination therapy improves effectiveness by mitigating the generation of anti-drug antibodies and enhancing the patient's response.
How Is the Segmentation of the Krystexxa Market Defined?
The krystexxa market covered in this report is segmented -
1) By Formulation: Injectable Formulation (Lyophilized Powder), Ready-To-Use Solutions
2) By Indication: Treatment Of Chronic Gout, Management Of Hyperuricemia In Gout Patients, Treatment Of Refractory Gout
3) By Patient Demographics: Adult Patients, Elderly Patients, Patients With Comorbid Conditions
4) By Distribution Channel: Direct Sales, Wholesalers And Distributors, Retail Pharmacies, Online Pharmacies
5) By End User: Hospitals, Specialty Clinics, Rheumatology Practices, Home Healthcare Providers
Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/krystexxa-global-market-report
What Is the Leading Region in the Krystexxa Market?
North America was the largest region in the krystexxa market in 2024. North America is expected to be the fastest-growing region in the forecast period. The regions covered in the krystexxa market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
What Is Covered In The Krystexxa Global Market Report?
- Market Size Analysis: Analyze the krystexxa Market Size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the krystexxa market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall krystexxa market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the krystexxa market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20134
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Rising Gout Incidence Driving Growth In Krystexxa Market: Major Factor in the Transformation of the Krystexxa Market in 2025 here
News-ID: 3874187 • Views: …
More Releases from The Business Research Company
Percutaneous Puncture Surgery Robot Market Analysis Highlights Growth To $3.54 B …
The market for percutaneous puncture surgery robots is on the verge of significant expansion, driven by rapid technological advances and increasing adoption in healthcare settings. As robotic systems become more sophisticated and integrated with cutting-edge technologies, this sector is set to transform minimally invasive surgical procedures. Below is a detailed exploration of the market's size, key players, trends, and segmentation that shape its future trajectory.
Projected Growth and Market Size of…
Pedicle Screw Systems Market Study Highlights How Industry Demand Is Evolving
The pedicle screw systems market is set to experience significant expansion in the coming years, driven by advancements in spinal surgery techniques and increasing patient demand. This market's evolution reflects growing medical needs and ongoing innovation, positioning it for substantial growth by 2030.
Forecasted Market Size and Growth Trajectory for Pedicle Screw Systems
The value of the pedicle screw systems market is projected to reach $7.65 billion by 2030, growing…
Pediatric Orthopedic Implants Market Research Reveals Strong 10.8% CAGR Outlook …
The pediatric orthopedic implants market is on track for significant expansion as advancements in technology and growing healthcare needs drive demand. Innovations in implant design and personalized treatment options are setting the stage for transformative growth in this specialized segment of medical devices. Below is a detailed overview of the current market size, key industry players, emerging trends, and segmentation that define this market's future.
Pediatric Orthopedic Implants Market Size and…
Pediatric Interventional Cardiology Market Intelligence Report Covers Trends, Se …
The pediatric interventional cardiology field is on track for significant expansion, driven by advances in medical technology and growing demand for specialized cardiac care for children. This sector is expected to see dynamic growth as innovative devices and techniques become more widely adopted to improve patient outcomes.
Projected Market Size and Growth Trajectory of the Pediatric Interventional Cardiology Market
The market for pediatric interventional cardiology is forecasted to grow steadily,…
More Releases for Krystexxa
Chronic Refractory Gout (CRG) Market is Projected to Witness Significant Growth …
The Chronic Refractory Gout (CRG) Market is growing due to the rising prevalence of chronic gout, uncontrolled hyperuricemia, and increasing demand for effective urate-lowering therapies. Growing awareness of treatment-resistant gout and the development of pipeline candidates such as NASP (SEL-212), ABP-671, and AR882 are expected to further drive market growth during the forecast period.
DelveInsight, a leading market research firm, announces the release of its latest report, "DelveInsight's Chronic Refractory Gout…
Emerging Sub-Segments Transforming the Krystexxa Market Landscape
The Krystexxa market is capturing attention due to its potential to address a growing patient base facing refractory gout. With increasing referrals to specialty clinics and the expansion of infusion services, the market is poised for steady growth. Additionally, supportive reimbursement policies for biologic treatments and the ongoing need for effective solutions in severe gout cases are driving this upward trend. Let's explore the market valuation, leading companies, emerging trends,…
Chronic Refractory Gout Market Size was valued ~USD 1,393 million in the 7MM in …
DelveInsight's "Chronic Refractory Gout Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Chronic Refractory Gout, historical and forecasted epidemiology as well as the Chronic Refractory Gout market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Chronic Refractory Gout market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Chronic Refractory Gout Market…
Global Krystexxa Market Outlook 2025-2034: Trends, Innovations, And Future Outlo …
The Krystexxa Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Krystexxa Market Size and Projected Growth Rate?
In recent times, the market size of Krystexxa has seen an XX (HCAGR). This market is projected to expand from $XX million in 2024 to $XX…
Key Trend Reshaping the Krystexxa Market in 2025: Innovative Therapies In Gout M …
Which drivers are expected to have the greatest impact on the over the krystexxa market's growth?
The Krystexxa market is anticipated to grow in response to the rising occurrence of gout disease. Gout is a form of arthritis induced by uric acid crystal accumulation in the joints, resulting in inflammation, pain, and swelling. This growing prevalence of gout is due to a variety of factors such as improper diet, obesity, aging,…
Rising Gout Incidence Driving Growth In Krystexxa Market: Major Factor in the Tr …
How Will the Krystexxa Market Grow, and What Is the Projected Market Size?
In recent times, the market size for krystexxa has seen a HCAGR of $XX. The projections show a growth from $XX million in 2024 to $XX million in 2025, with a Compound Annual Growth Rate (CAGR) of $XX%. The historic period growth has been driven by factors such as an increasing geriatric population, a surge in clinical studies,…
